Weld Capital Management’s AbbVie ABBV Stock Holding History

Weld Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-5,212	Closed	-$587K	–	2
2021 Q2	$587K	Sell	5,212 -1,401	-21%	-$158K	0.59%	51
2021 Q1	$716K	Buy	+6,613	New	+$707K	0.3%	128
2020 Q3	–	Sell	-2,501	Closed	-$246K	–	463
2020 Q2	$246K	Sell	2,501 -7,796	-76%	-$686K	0.1%	333
2020 Q1	$785K	Sell	10,297 -9,151	-47%	-$779K	0.4%	72
2019 Q4	$1.72M	Buy	19,448 +4,211	+28%	+$350K	0.33%	84
2019 Q3	$1.15M	Sell	15,237 -1,280	-8%	-$87.8K	0.21%	130
2019 Q2	$1.2M	Buy	+16,517	New	+$1.3M	0.22%	137

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Weld Capital Management's ABBV Position: Q3 2021 in Review

Weld Capital Management sold out of AbbVie (ABBV) in Q3 2021, closing a stake of 5,212 shares — an estimated $587K sold.

Weld Capital Management first reported a position in ABBV in Q2 2019 and held it in 7 quarters. The position peaked at $1.72M in Q4 2019. 2,656 funds tracked by Wall St. Rank hold ABBV as of Q3 2021.

Weld Capital Management reported no remaining AbbVie position as of Q3 2021 after selling out during the quarter.
Weld Capital Management sold 5,212 AbbVie shares in Q3 2021, an estimated $587K.
Weld Capital Management first reported a position in AbbVie in Q2 2019 and held it in 7 quarters.
Weld Capital Management's AbbVie position peaked at $1.72M in Q4 2019.
2,656 funds tracked by Wall St. Rank held AbbVie as of Q3 2021.

Based on Weld Capital Management's 13F filing for Q3 2021.